发明名称 |
Splice-region antisense composition and method |
摘要 |
Antisense compositions targeted against an mRNA sequence coding for a selected protein, at a region having its 5′ end from 1 to about 25 base pairs downstream of a normal splice acceptor junction in the preprocessed mRNA, are disclosed. The antisense compound is RNase-inactive, and is preferably a phosphorodiamidate-linked morpholino oligonucleotide. Such targeting is effective to inhibit natural mRNA splice processing, produce splice variant mRNAs, and inhibit normal expression of the protein. |
申请公布号 |
US9416361(B2) |
申请公布日期 |
2016.08.16 |
申请号 |
US201414535098 |
申请日期 |
2014.11.06 |
申请人 |
Sarepta Therapeutics, Inc. |
发明人 |
Iversen Patrick L.;Hudziak Robert |
分类号 |
C07H21/02;C07H21/04;C12N15/113 |
主分类号 |
C07H21/02 |
代理机构 |
Seed IP Law Group PLLC |
代理人 |
Seed IP Law Group PLLC |
主权项 |
1. An oligomer of 8 to 40 morpholino subunits connected by phosphorous-containing intersubunit linkages, wherein the 5′ terminal morpholino subunit comprises a group of the formula: wherein each R1 is independently a C1-C6 alkyl. |
地址 |
Cambridge MA US |